期刊文献+

ASC-US患者HPV感染与Th17/Treg细胞及炎症因子的变化分析 被引量:4

下载PDF
导出
摘要 目的探讨未明确意义的非典型鳞状细胞(ASC-US)患者人类乳头状病毒(HPV)感染与外周血T17细胞/调解性T细胞(Th17/Treg)、炎症因子的变化分析。方法选取2017年3月至2017年12月于我院妇科门诊确诊200例ASC-US患者,根据宫颈活检组织学诊断将其分为宫颈炎性病变患者52例(炎性组)、宫颈上皮内瘤变患者133例(CIN组)、宫颈癌患者15例(宫颈癌组),对比三组宫颈标本中的HPV感染分型、外周血Th17/Treg细胞及血清白细胞介素-17(IL-17)、转化生长因子-β(TGF-β)、白细胞介素-23(IL-23)。结果宫颈癌组患者的HPV16型、HPV52型均显著的高于CIN组和炎性组(P<0.05),CIN组患者的HPV16型、HPV52型均显著的高于炎性组(P<0.05);宫颈癌组、CIN组和炎性组患者的HPV18型、HPV58型感染率差异无统计学意义(P>0.05);宫颈癌组患者的外周血中CD4+IL17+Th17、CD4+CD25+Foxp3+Treg、Th17/Treg细胞均显著的高于CIN组和炎性组(P<0.05),CIN组患者的CD4+IL17+Th17、CD4+CD25+Foxp3+Treg、Th17/Treg均显著的高于炎性组(P<0.05);宫颈癌组患者的血清IL-17、TGF-β、IL-23均显著的高于CIN组和炎性组(P<0.05),CIN组患者的血清IL-17、TGF-β、IL-23均显著的高于炎性组(P<0.05)。结论宫颈癌组织中HPV16型、HPV52型感染率较高,并且存在免疫功能紊乱及炎症反应增强的表现。
出处 《实验与检验医学》 CAS 2020年第2期334-337,共4页 Experimental and Laboratory Medicine
  • 相关文献

参考文献12

二级参考文献57

  • 1宫颈癌及癌前病变规范化诊疗指南(试行)[J].慢性病学杂志,2013(6):401-410. 被引量:98
  • 2Ronco G, Giorgi-Rossi P, Carozzi F, et al. Efficacy of human papillomavirus testingfor the detection of invasive cervical cancers and cervical intraepithelialneoplasia: a randomised controlled trial. Lancet Oncol, 2010, 11:249 - 257.
  • 3Katki HA, Kirmey WK, Fetterman B, et al. Cervical cancer risk for womenundergoing concurrent testing for human papillomavir- us and cervical cytology: apopulation-based study in routine clini- cal practice Lancet Oncol, 2011, 12.. 663-672.
  • 4Wright TC, Mark H, Stoler B, et al, Primary cervical cancer screening with human papillomavirus: End of study results from the ATHENAstudy using HPV as the first-line screen- ing test. GynecolOncol, 2015, 136: 189-197.
  • 5Huh WK, Ault KA, Chelmow D, et al. Use of primary high-risk human papillomavirus testing for cervical cancer screening: Interim cliniealguidance. Gynecol Oncol, 2015, 136: 178-182.
  • 6Enarsson K,Lundin BS,Johnsson E,et al. CD4+ CD25high regulatory T cells reduce T cell transendothelial migration in cancer patients[J]. Eur J Immunol, 2007, 37:282-291.
  • 7Shibuya K, Mathers CD, Boschi-Pinto C, et al. Global and regional estimates of cancer mortality and incidence by site: II. Results for the global burden of disease 2000 [ J]. BMC Cancer, 2002. 2:37.
  • 8Roy S, Barik S, Banerjee S, et al. Neem leaf glycoprotein overcomes indoleamine 2,3 dioxygenase mediated tolerance in dendritic ceils by attenuating hyperactive regulatory T cells in cervical cancer stage IIIB patients [ J ]. Hum Immunol, 2013, 74 : 1015-1023.
  • 9Chen ML, Pittet M J, Gorelik L, et al. Regulatory T cells suppress tumor-specific CD8 T cell cytotoxicity through TGF-beta signals in vivo[J]. Proc Natl Acad Sci U S A, 2005, 102:419-424.
  • 10Terabe M, Berzofsky JA. Immunoregulatory T ceils in tumor immunity [J]. Curr Opin Immunol, 2004, 16:157-162.

共引文献160

同被引文献72

引证文献4

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部